According to Britannia Life Sciences latest financial reports the cash on hand of BLAB is $1.92M, an increase of 59.29% to 2022. At the end of 2022 company had $1.20M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $1.92M | 59.29% |
2022 | $1.20M | 96.92% |
2021 | $610.59K | - |